Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
15.95
-0.18 (-1.12%)
At close: May 29, 2026, 4:00 PM EDT
15.64
-0.31 (-1.94%)
After-hours: May 29, 2026, 7:53 PM EDT
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $838.42 million as of May 29, 2026. Its market cap has increased by 2,006.59% in one year.
Market Cap
838.42M
Enterprise Value
756.76M
1-Year Change
2,006.59%
Ranking
Category
Stock Price
$15.95
Market Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $838.42M, an increase of 2,330.21%. That is a compound annual growth rate of 35.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 847.90M | 157.49% |
| Dec 31, 2025 | 329.30M | 326.55% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
| Nov 13, 2015 | 34.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kura Oncology | 885.08M |
| Annexon | 879.83M |
| ORIC Pharmaceuticals | 874.72M |
| Bright Minds Biosciences | 872.67M |
| Sana Biotechnology | 871.05M |
| Odyssey Therapeutics | 845.36M |
| Evommune | 840.31M |
| Theravance Biopharma | 835.67M |